Attached files

file filename
8-K - CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES - SILICON LABORATORIES INC.a16-20338_18k.htm

Exhibit 99

 

 

SILICON LABS ANNOUNCES RECORD REVENUE FOR THIRD QUARTER 2016

 

Exceeds Guidance on Revenue, Gross Margin and EPS

 

AUSTIN, Texas — Oct. 26, 2016 — Silicon Labs (NASDAQ: SLAB), a leading provider of silicon, software and solutions for a smarter, more connected world, today reported financial results for its third quarter ended October 1, 2016. Revenue in the third quarter established a new record, exceeding the high end of guidance at $178.1 million, up from $174.9 million in the second quarter. Third quarter GAAP and non-GAAP earnings per share (EPS) exceeded the high end of guidance at $0.47 and $0.77, respectively.

 

Third Quarter Financial Highlights

 

·                  IoT revenue established a new record, increasing to $81.5 million, or 6.2% sequentially.

·                  Infrastructure revenue established a new record, increasing to $38.3 million, or 7.5% sequentially, exclusive of $5 million of patent sale revenue in the second quarter.

·                  Broadcast increased to $40.7 million, or 7.1% sequentially.

·                  Access revenue declined to $17.5 million, or 10.0% sequentially.

 

On a GAAP basis:

 

·                  GAAP gross margin was 60.8%.

·                  GAAP R&D expenses were $48.4 million.

·                  GAAP SG&A expenses were $38.0 million.

·                  GAAP operating income as a percentage of revenue was 12.2%.

·                  GAAP diluted earnings per share were $0.47.

 

On a non-GAAP basis (results exclude the impact of stock compensation, amortization of acquired intangible assets and certain other items as set forth in the reconciliation tables below):

 

·                  Non-GAAP gross margin was 61.0%.

·                  Non-GAAP R&D expenses were $39.6 million.

·                  Non-GAAP SG&A expenses were $31.4 million.

·                  Non-GAAP operating income as a percentage of revenue was 21.1%.

·                  Non-GAAP diluted earnings per share were $0.77.

 



 

Product Highlights

 

·                  Acquired Micrium, the leading supplier of real-time operating system (RTOS) software for embedded computing, supporting more than 50 processor architectures and providing a commercial-grade RTOS solution across key embedded markets.

·                  Launched the MGM111 mesh networking module, leveraging Silicon Labs’ multiprotocol Mighty Gecko SoC, ZigBee® and Thread mesh protocol stacks, and Simplicity Studio™ development tools.

·                  Shipped more than 100 million ZigBee mesh networking devices worldwide to date, reaching a new milestone.

·                  Released a major update of the award-winning Simplicity Studio software development tools, giving IoT developers more capabilities and easier access to Silicon Labs’ full range of IoT products, including its latest multiprotocol wireless SoCs.

·                  Launched the CP2102N bridge device, a smaller, lower-power offering of Silicon Labs’ USBXpress™ family providing a highly integrated, turnkey solution for adding USB connectivity to embedded designs.

·                  Introduced the Si875x isolated gate drivers offering an innovative capability to transfer power across an integrated CMOS isolation barrier, and providing a replacement solution for antiquated electromechanical relays and optocoupler-based solid-state relays in switching applications.

·                  Launched the Si828x isolated gate driver family targeting industrial and green energy designs requiring state-of-the-art signal isolation technology with superior timing, lower emissions and higher reliability.

·                  Introduced the Si838x isolator family of high-speed, multi-channel digital isolation products designed to outperform and outlive legacy optocouplers in programmable logic controllers for factory automation.

 

Business Outlook

 

The company expects revenue in the fourth quarter to be in the range of $176 million to $181 million. Fourth quarter diluted earnings per share are expected to be between $0.30 and $0.36 on a GAAP basis, and between $0.62 and $0.68 on a non-GAAP basis.

 

“We are delighted to report record revenue, including five percent sequential and 14 percent year-on-year growth in product revenue,” said Tyson Tuttle, CEO of Silicon Labs. “We are executing on our growth strategy targeting the IoT and Infrastructure markets, and are seeing our efforts translate into strong financial results.”

 



 

Webcast and Conference Call

 

A conference call discussing the quarterly results will follow this press release at 7:30 a.m. Central time. An audio webcast will be available on Silicon Labs’ website (www.silabs.com) under Investor Relations. A replay will be available after the call at the same website listed above or by calling 1 (855) 859-2056 or (404) 537-3406 (international) and entering conference ID 83473959. The replay will be available through November 26, 2016.

 

About Silicon Labs

 

Silicon Labs (NASDAQ: SLAB) is a leading provider of silicon, software and solutions for the Internet of Things, Infrastructure, industrial automation, consumer and automotive markets. We solve the electronics industry’s toughest problems, providing customers with significant advantages in performance, energy savings, connectivity and design simplicity. Backed by our world-class engineering teams with strong software and mixed-signal design expertise, Silicon Labs empowers developers with the tools and technologies they need to advance quickly and easily from initial idea to final product. www.silabs.com

 

Forward-Looking Statements

 

This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “plan,” “project,” “will” and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing our distributors, manufacturers and subcontractors; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against our products and our networks; conflict mineral risks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

 

Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, the Silicon Labs logo, Simplicity Studio, and USBXpress are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

 

CONTACT: Jalene Hoover, +1 (512) 428-1610, Jalene.Hoover@silabs.com

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

October 1,
2016

 

October 3,
2015

 

October 1,
2016

 

October 3,
2015

 

Revenues

 

$

178,083

 

$

156,194

 

$

515,016

 

$

484,755

 

Cost of revenues

 

69,880

 

62,759

 

202,988

 

197,523

 

Gross margin

 

108,203

 

93,435

 

312,028

 

287,232

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

48,437

 

46,483

 

149,118

 

140,805

 

Selling, general and administrative

 

38,034

 

35,729

 

116,716

 

118,989

 

Operating expenses

 

86,471

 

82,212

 

265,834

 

259,794

 

Operating income

 

21,732

 

11,223

 

46,194

 

27,438

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

331

 

186

 

880

 

544

 

Interest expense

 

(643

)

(687

)

(1,939

)

(2,160

)

Other, net

 

(58

)

(280

)

(431

)

218

 

Income before income taxes

 

21,362

 

10,442

 

44,704

 

26,040

 

Provision for income taxes

 

1,344

 

467

 

3,319

 

2,112

 

Net income

 

$

20,018

 

$

9,975

 

$

41,385

 

$

23,928

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.48

 

$

0.24

 

$

0.99

 

$

0.56

 

Diluted

 

$

0.47

 

$

0.23

 

$

0.98

 

$

0.55

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

41,614

 

42,331

 

41,673

 

42,522

 

Diluted

 

42,307

 

42,795

 

42,263

 

43,135

 

 



 

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

 

 

 

Three Months Ended
October 1, 2016

 

Non-GAAP Income 
Statement Items

 

GAAP
Measure

 

GAAP
Percent of
Revenue

 

Stock
Compensation
Expense

 

Intangible 
Asset
Amortization

 

Acquisition
Related
Items

 

Termination
Costs

 

Non-GAAP
Measure

 

Non-GAAP
Percent of
Revenue

 

Revenues

 

$

178,083

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

108,203

 

60.8

%

$

272

 

$

130

 

$

 

$

 

$

108,605

 

61.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

48,437

 

27.2

%

4,580

 

4,257

 

 

 

39,600

 

22.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

38,034

 

21.4

%

4,343

 

1,420

 

311

 

552

 

31,408

 

17.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

21,732

 

12.2

%

9,195

 

5,807

 

311

 

552

 

37,597

 

21.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
October 1, 2016

 

 

 

Non-GAAP
Earnings Per Share

 

GAAP
Measure

 

Stock
Compensation
Expense*

 

Intangible 
Asset
Amortization*

 

Acquisition
Related 
Items*

 

Termination 
Costs*

 

Income Tax
Adjustments

 

Non-GAAP
Measure

 

 

 

Net income

 

$

20,018

 

$

9,195

 

$

5,807

 

$

311

 

$

552

 

$

(3,467

)

$

32,416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted shares outstanding

 

42,307

 

 

 

 

 

 

 

 

 

 

 

42,307

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.47

 

 

 

 

 

 

 

 

 

 

 

$

0.77

 

 

 

 


* Represents pre-tax amounts

 

Unaudited Forward-Looking Statements Regarding Business Outlook

 

 

 

Three Months Ending
December 31, 2016

 

 

 

 

 

 

 

 

 

Business Outlook

 

High

 

Low

 

 

 

 

 

 

 

 

 

Estimated GAAP diluted earnings per share

 

$

0.36

 

$

0.30

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated non-GAAP charges

 

0.32

 

0.32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated non-GAAP diluted earnings per share

 

$

0.68

 

$

0.62

 

 

 

 

 

 

 

 

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

 

 

 

October 1,
2016

 

January 2,
2016

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

148,195

 

$

114,085

 

Short-term investments

 

131,139

 

128,901

 

Accounts receivable, net

 

84,923

 

73,601

 

Inventories

 

55,051

 

53,895

 

Prepaid expenses and other current assets

 

49,087

 

52,658

 

Total current assets

 

468,395

 

423,140

 

Long-term investments

 

6,980

 

7,126

 

Property and equipment, net

 

130,318

 

131,132

 

Goodwill

 

272,722

 

272,722

 

Other intangible assets, net

 

100,320

 

121,354

 

Other assets, net

 

51,481

 

55,989

 

Total assets

 

$

1,030,216

 

$

1,011,463

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

39,591

 

$

42,127

 

Current portion of long-term debt

 

 

10,000

 

Accrued expenses

 

51,561

 

52,131

 

Deferred income on shipments to distributors

 

47,057

 

35,448

 

Income taxes

 

5,638

 

2,615

 

Total current liabilities

 

143,847

 

142,321

 

Long-term debt

 

72,500

 

67,500

 

Other non-current liabilities

 

26,240

 

40,528

 

Total liabilities

 

242,587

 

250,349

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock — $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock — $0.0001 par value; 250,000 shares authorized; 41,651 and 41,727 shares issued and outstanding at October 1, 2016 and January 2, 2016, respectively

 

4

 

4

 

Additional paid-in capital

 

6,344

 

13,868

 

Retained earnings

 

781,890

 

747,749

 

Accumulated other comprehensive loss

 

(609

)

(507

)

Total stockholders’ equity

 

787,629

 

761,114

 

Total liabilities and stockholders’ equity

 

$

1,030,216

 

$

1,011,463

 

 



 

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Nine Months Ended

 

 

 

October 1,
2016

 

October 3,
2015

 

Operating Activities

 

 

 

 

 

Net income

 

$

41,385

 

$

23,928

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

Depreciation of property and equipment

 

9,912

 

9,293

 

Amortization of other intangible assets and other assets

 

21,461

 

21,686

 

Stock-based compensation expense

 

30,057

 

30,798

 

Income tax benefit (shortfall) from stock-based awards

 

(1,238

)

1,727

 

Excess income tax benefit from stock-based awards

 

(373

)

(2,118

)

Deferred income taxes

 

(1,460

)

1,571

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(11,322

)

12,097

 

Inventories

 

(1,558

)

2,259

 

Prepaid expenses and other assets

 

7,404

 

8,409

 

Accounts payable

 

1,280

 

(5,686

)

Accrued expenses

 

8,930

 

(280

)

Deferred income on shipments to distributors

 

11,573

 

(2,825

)

Income taxes

 

1,459

 

(3,413

)

Other non-current liabilities

 

(10,891

)

(10,031

)

Net cash provided by operating activities

 

106,619

 

87,415

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

Purchases of available-for-sale investments

 

(131,741

)

(55,433

)

Sales and maturities of available-for-sale investments

 

129,511

 

136,262

 

Purchases of property and equipment

 

(8,545

)

(7,281

)

Purchases of other assets

 

(4,994

)

(5,291

)

Acquisition of business, net of cash acquired

 

 

(76,899

)

Net cash used in investing activities

 

(15,769

)

(8,642

)

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

Proceeds from issuance of long-term debt, net

 

 

81,238

 

Payments on debt

 

(5,000

)

(92,206

)

Repurchases of common stock

 

(40,543

)

(71,448

)

Payment of taxes withheld for vested stock awards

 

(10,521

)

(12,652

)

Proceeds from the issuance of common stock

 

8,451

 

12,575

 

Excess income tax benefit from stock-based awards

 

373

 

2,118

 

Payment of acquisition-related contingent consideration

 

(9,500

)

(4,464

)

Net cash used in financing activities

 

(56,740

)

(84,839

)

 

 

 

 

 

 

Decrease in cash and cash equivalents

 

34,110

 

(6,066

)

Cash and cash equivalents at beginning of period

 

114,085

 

141,706

 

Cash and cash equivalents at end of period

 

$

148,195

 

$

135,640